Literature DB >> 1310698

Human cytomegalovirus-stimulated peripheral blood mononuclear cells induce HIV-1 replication via a tumor necrosis factor-alpha-mediated mechanism.

P K Peterson1, G Gekker, C C Chao, S X Hu, C Edelman, H H Balfour, J Verhoef.   

Abstract

Human cytomegalovirus (HCMV) is a potential cofactor in HIV-1 infection. To investigate the mechanism whereby HCMV promotes HIV-1 replication, a PBMC coculture assay which measures HIV-1 p24 antigen release was used as an index of viral replication. HCMV-stimulated PBMC were capable of inducing HIV-1 replication in cocultures with acutely infected PBMC; however, this occurred only when the PBMC were from HCMV-seropositive donors (598 +/- 207 versus 27 +/- 10 pg/ml p24 antigen with PBMC from HCMV-seronegative donors on day 6 of coculture). Upon stimulation with HCMV, PBMC obtained exclusively from HCMV-seropositive donors released tumor necrosis factor (TNF)-alpha (270 +/- 79 pg/ml at 18 h of culture). Monoclonal antibodies to TNF-alpha blocked the activity of HCMV-stimulated PBMC in cocultures both with acutely HIV-1-infected PBMC and with the chronically infected promonocytic line U1. Also, treatment of HCMV-stimulated PBMC with pentoxifylline, an inhibitor of TNF-alpha mRNA, markedly reduced HIV-1 replication in cocultures both with acutely and chronically infected cells. These results indicate that TNF-alpha is a key mediator of HIV-1 replication induced by HCMV-stimulated PBMC and support the concept that this cytokine plays an important role in the pathogenesis of HIV-1 infection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1310698      PMCID: PMC442890          DOI: 10.1172/JCI115623

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  45 in total

1.  Molecular interactions between human immunodeficiency virus type 1 and human cytomegalovirus.

Authors:  P A Barry; E Pratt-Lowe; D J Alcendor; R E Unger; P A Luciw
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

2.  Antiviral activity of tumour necrosis factor. Synergism with interferons and induction of oligo-2',5'-adenylate synthetase.

Authors:  J Mestan; M Brockhaus; H Kirchner; H Jacobsen
Journal:  J Gen Virol       Date:  1988-12       Impact factor: 3.891

3.  Tumor necrosis factor-alpha production of influenza A virus-infected macrophages and potentiating effect of lipopolysaccharides.

Authors:  M Nain; F Hinder; J H Gong; A Schmidt; A Bender; H Sprenger; D Gemsa
Journal:  J Immunol       Date:  1990-09-15       Impact factor: 5.422

4.  Cytomegalovirus infection of human blood cells.

Authors:  L Einhorn; A Ost
Journal:  J Infect Dis       Date:  1984-02       Impact factor: 5.226

5.  Cytokine regulation of HIV expression.

Authors:  A S Fauci
Journal:  Lymphokine Res       Date:  1990

6.  Cytocidal effect of tumor necrosis factor on cells chronically infected with human immunodeficiency virus (HIV): enhancement of HIV replication.

Authors:  T Matsuyama; Y Hamamoto; G Soma; D Mizuno; N Yamamoto; N Kobayashi
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

7.  Cytomegalovirus enhances lysis of HIV-infected T lymphoblasts.

Authors:  D Casareale; M Fiala; C M Chang; L A Cone; E S Mocarski
Journal:  Int J Cancer       Date:  1989-07-15       Impact factor: 7.396

8.  Cyclic nucleotides differentially regulate the synthesis of tumour necrosis factor-alpha and interleukin-1 beta by human mononuclear cells.

Authors:  S Endres; H J Fülle; B Sinha; D Stoll; C A Dinarello; R Gerzer; P C Weber
Journal:  Immunology       Date:  1991-01       Impact factor: 7.397

9.  Human immunodeficiency virus-1 infection of macrophages in vitro neither induces tumor necrosis factor (TNF)/cachectin gene expression nor alters TNF/cachectin induction by lipopolysaccharide.

Authors:  J R Munis; D D Richman; R S Kornbluth
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

10.  Tumor necrosis factor-alpha/cachectin enhances human immunodeficiency virus type 1 replication in primary macrophages.

Authors:  J W Mellors; B P Griffith; M A Ortiz; M L Landry; J L Ryan
Journal:  J Infect Dis       Date:  1991-01       Impact factor: 5.226

View more
  24 in total

Review 1.  Molecular pathways in virus-induced cytokine production.

Authors:  T H Mogensen; S R Paludan
Journal:  Microbiol Mol Biol Rev       Date:  2001-03       Impact factor: 11.056

Review 2.  Application of structural dynamic approaches provide novel insights into the enzymatic mechanism of the tumor necrosis factor-alpha-converting enzyme.

Authors:  Irit Sagi; Marcos E Milla
Journal:  Anal Biochem       Date:  2007-09-26       Impact factor: 3.365

3.  Soluble tumor necrosis factor alpha receptors (sTNF-Rs) in HIV-1-infected intravenous drug users: change in circulating sTNF-R type II level and survival for AIDS patients.

Authors:  F Ajello; R La Licata; M Lodato; F Vitale; F Bonura; R Valenti; M Bruno; N Romano
Journal:  Eur J Epidemiol       Date:  2000-03       Impact factor: 8.082

4.  Human cytomegalovirus-induced immunosuppression. Relationship to tumor necrosis factor-dependent release of arachidonic acid and prostaglandin E2 in human monocytes.

Authors:  M A Nokta; M I Hassan; K Loesch; R B Pollard
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

5.  Production of tumor necrosis factor alpha in human leukocytes stimulated by Cryptococcus neoformans.

Authors:  S M Levitz; A Tabuni; H Kornfeld; C C Reardon; D T Golenbock
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

Review 6.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

7.  CT-2576, an inhibitor of phospholipid signaling, suppresses constitutive and induced expression of human immunodeficiency virus.

Authors:  D W Leung; P K Peterson; R Weeks; G Gekker; C C Chao; A H Kaplan; N Balantac; C Tompkins; G E Underiner; S Bursten
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

8.  Differences in cytokine secretion by intestinal mononuclear cells, peripheral blood monocytes and alveolar macrophages from HIV-infected patients.

Authors:  M Steffen; H C Reinecker; J Petersen; C Doehn; I Pflüger; A Voss; A Raedler
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

9.  Multiparameter analysis of clastogenic factors, pro-oxidant cytokines, and inflammatory markers in HIV-1-infected patients with asymptomatic disease, opportunistic infections, and malignancies.

Authors:  J Fuchs; N Oelke; M Imhof; F Ochsendorf; H Schöfer; G Oromek; A Alaoui-Youssefi; I Emerit
Journal:  Mol Med       Date:  1998-05       Impact factor: 6.354

10.  The effects of cytomegalovirus on human immunodeficiency virus replication in brain-derived cells correlate with permissiveness of the cells for each virus.

Authors:  F M Jault; S A Spector; D H Spector
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.